Erythropoietin treatment in chronic phase chronic myeloid leukemia patients treated with frontline imatinib who developed late anemia.

Cesini, Laura

Erythropoietin treatment in chronic phase chronic myeloid leukemia patients treated with frontline imatinib who developed late anemia. [electronic resource] - European journal of haematology Sep 2020 - 286-291 p. digital

Publication Type: Journal Article; Multicenter Study

1600-0609

10.1111/ejh.13436 doi


Aged
Anemia--blood
Antineoplastic Agents--adverse effects
Biomarkers
Disease Management
Disease Susceptibility
Erythrocyte Indices
Erythropoietin--administration & dosage
Female
Humans
Imatinib Mesylate--adverse effects
Leukemia, Myeloid, Chronic-Phase--complications
Male
Middle Aged
Protein Kinase Inhibitors--adverse effects
Treatment Outcome